Drug Mechanism of Action-based targeting of tumor subpopulations
$164,500U54FY2024CANIH
Columbia University Health Sciences, New York NY
Investigators
Linked publications & trials
Paper 39374382Paper 39314954Paper 38886159Paper 38724493Paper 38640504Paper 38588697Paper 38454137Paper 38286827Paper 38172131Paper 38114518Paper 37966260Paper 37873470
Abstract
The primary site of prostate cancer metastasis is bone, which is associated with significant morbidity and mortality; yet there are few curative treatment options, in part due to the characteristic heterogeneity of prostate cancer. Our studies employ novel in vivo models and advanced technological approaches to elucidate tumor cell intrinsic and tumor cell extrinsic mechanisms underlying bone metastasis and response to drug treatment. Our studies may provide new insights that will fine-tune treatment with metastatic prostate cancer.
View original record on NIH RePORTER →